| molecular function |
|---|
| | GO:0005524 | | ATP binding | | Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator. |
| | GO:0035529 | | NADH pyrophosphatase activity | | Catalysis of the reaction: NADH + H2O = AMP + NMNH + 2 H+. |
| | GO:0005509 | | calcium ion binding | | Interacting selectively and non-covalently with calcium ions (Ca2+). |
| | GO:0003824 | | catalytic activity | | Catalysis of a biochemical reaction at physiological temperatures. In biologically catalyzed reactions, the reactants are known as substrates, and the catalysts are naturally occurring macromolecular substances known as enzymes. Enzymes possess specific binding sites for substrates, and are usually composed wholly or largely of protein, but RNA that has catalytic activity (ribozyme) is often also regarded as enzymatic. |
| | GO:0016787 | | hydrolase activity | | Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3. |
| | GO:0005158 | | insulin receptor binding | | Interacting selectively and non-covalently with the insulin receptor. |
| | GO:0046872 | | metal ion binding | | Interacting selectively and non-covalently with any metal ion. |
| | GO:0003676 | | nucleic acid binding | | Interacting selectively and non-covalently with any nucleic acid. |
| | GO:0047429 | | nucleoside-triphosphate diphosphatase activity | | Catalysis of the reaction: H2O + a nucleoside triphosphate = diphosphate + a nucleotide. |
| | GO:0004551 | | nucleotide diphosphatase activity | | Catalysis of the reaction: a dinucleotide + H2O = 2 mononucleotides. |
| | GO:0004528 | | phosphodiesterase I activity | | Catalysis of the sequential hydrolytic removal of 5'-nucleotides from the 3'-hydroxy termini of 3'-hydroxy-terminated oligonucleotides. |
| | GO:0030247 | | polysaccharide binding | | Interacting selectively and non-covalently with any polysaccharide, a polymer of many (typically more than 10) monosaccharide residues linked glycosidically. |
| | GO:0042803 | | protein homodimerization activity | | Interacting selectively and non-covalently with an identical protein to form a homodimer. |
| | GO:0005044 | | scavenger receptor activity | | Combining with any modified low-density lipoprotein (LDL) or other polyanionic ligand and delivering the ligand into the cell via endocytosis. Ligands include acetylated and oxidized LDL, Gram-positive and Gram-negative bacteria, apoptotic cells, amyloid-beta fibrils, and advanced glycation end products (AGEs). |
| | GO:0008270 | | zinc ion binding | | Interacting selectively and non-covalently with zinc (Zn) ions. |
| biological process |
|---|
| | GO:0050427 | | 3'-phosphoadenosine 5'-phosphosulfate metabolic process | | The chemical reactions and pathways involving 3'-phosphoadenosine 5'-phosphosulfate, a naturally occurring mixed anhydride. It is an intermediate in the formation of a variety of sulfo compounds in biological systems. |
| | GO:0031214 | | biomineral tissue development | | Formation of hard tissues that consist mainly of inorganic compounds, and also contain a small amounts of organic matrices that are believed to play important roles in their formation. |
| | GO:0046849 | | bone remodeling | | The continuous turnover of bone matrix and mineral that involves first, an increase in resorption (osteoclastic activity) and later, reactive bone formation (osteoblastic activity). The process of bone remodeling takes place in the adult skeleton at discrete foci. The process ensures the mechanical integrity of the skeleton throughout life and plays an important role in calcium homeostasis. An imbalance in the regulation of bone resorption and bone formation results in many of the metabolic bone diseases, such as osteoporosis. |
| | GO:0030643 | | cellular phosphate ion homeostasis | | Any process involved in the maintenance of an internal steady state of phosphate ions at the level of a cell. |
| | GO:0032869 | | cellular response to insulin stimulus | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an insulin stimulus. Insulin is a polypeptide hormone produced by the islets of Langerhans of the pancreas in mammals, and by the homologous organs of other organisms. |
| | GO:0006091 | | generation of precursor metabolites and energy | | The chemical reactions and pathways resulting in the formation of precursor metabolites, substances from which energy is derived, and any process involved in the liberation of energy from these substances. |
| | GO:0006955 | | immune response | | Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat. |
| | GO:0030505 | | inorganic diphosphate transport | | The directed movement of inorganic diphosphate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. |
| | GO:0008152 | | metabolic process | | The chemical reactions and pathways, including anabolism and catabolism, by which living organisms transform chemical substances. Metabolic processes typically transform small molecules, but also include macromolecular processes such as DNA repair and replication, and protein synthesis and degradation. |
| | GO:0030308 | | negative regulation of cell growth | | Any process that stops, prevents, or reduces the frequency, rate, extent or direction of cell growth. |
| | GO:0045599 | | negative regulation of fat cell differentiation | | Any process that stops, prevents, or reduces the frequency, rate or extent of adipocyte differentiation. |
| | GO:0046325 | | negative regulation of glucose import | | Any process that stops, prevents, or reduces the frequency, rate or extent of the import of the hexose monosaccharide glucose into a cell or organelle. |
| | GO:0045719 | | negative regulation of glycogen biosynthetic process | | Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of glycogen. |
| | GO:0046627 | | negative regulation of insulin receptor signaling pathway | | Any process that stops, prevents, or reduces the frequency, rate or extent of insulin receptor signaling. |
| | GO:0030279 | | negative regulation of ossification | | Any process that stops, prevents, or reduces the frequency, rate or extent of bone formation. |
| | GO:0031953 | | negative regulation of protein autophosphorylation | | Any process that stops, prevents or decreases the rate of the phosphorylation by a protein of one or more of its own residues. |
| | GO:0090305 | | nucleic acid phosphodiester bond hydrolysis | | The nucleic acid metabolic process in which the phosphodiester bonds between nucleotides are cleaved by hydrolysis. |
| | GO:0009143 | | nucleoside triphosphate catabolic process | | The chemical reactions and pathways resulting in the breakdown of a nucleoside triphosphate, a compound consisting of a nucleobase linked to a deoxyribose or ribose sugar esterified with triphosphate on the sugar. |
| | GO:0006796 | | phosphate-containing compound metabolic process | | The chemical reactions and pathways involving the phosphate group, the anion or salt of any phosphoric acid. |
| | GO:0006898 | | receptor-mediated endocytosis | | An endocytosis process in which cell surface receptors ensure specificity of transport. A specific receptor on the cell surface binds tightly to the extracellular macromolecule (the ligand) that it recognizes; the plasma-membrane region containing the receptor-ligand complex then undergoes endocytosis, forming a transport vesicle containing the receptor-ligand complex and excluding most other plasma-membrane proteins. Receptor-mediated endocytosis generally occurs via clathrin-coated pits and vesicles. |
| | GO:0030730 | | sequestering of triglyceride | | The process of binding or confining any triester of glycerol such that it is separated from other components of a biological system. |
| cellular component |
|---|
| | GO:0016323 | | basolateral plasma membrane | | The region of the plasma membrane that includes the basal end and sides of the cell. Often used in reference to animal polarized epithelial membranes, where the basal membrane is the part attached to the extracellular matrix, or in plant cells, where the basal membrane is defined with respect to the zygotic axis. |
| | GO:0009986 | | cell surface | | The external part of the cell wall and/or plasma membrane. |
| | GO:0005576 | | extracellular region | | The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite. |
| | GO:0005615 | | extracellular space | | That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid. |
| | GO:0016021 | | integral component of membrane | | The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
| | GO:0005887 | | integral component of plasma membrane | | The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
| | GO:0005765 | | lysosomal membrane | | The lipid bilayer surrounding the lysosome and separating its contents from the cell cytoplasm. |
| | GO:0016020 | | membrane | | A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it. |
| | GO:0005886 | | plasma membrane | | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
Description
